speb/financial-data huggingface dataset:
CHCI income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 17051000.00
CHCI income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 13475000.00
CHCI income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 17051000.00
CHCI income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 13475000.00
CHCI cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 17051000.00
CHCI cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 13475000.00
CHCI income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 17051000.00
CHCI income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 13475000.00
CHCI income_statement (annual, 2025-12-31) — Net Interest Income: 807000.00
CHCI income_statement (quarterly, 2025-12-31) — Net Interest Income: 185000.00
CHCI cash_flow (annual, 2025-12-31) — Net Investment Properties Purchase And Sale: 232000.00
CHCI cash_flow (quarterly, 2025-12-31) — Net Investment Properties Purchase And Sale: 1263000.00
CHCI cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -365000.00
CHCI cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 37000.00
CHCI income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 807000.00
CHCI income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 185000.00
CHCI cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -626000.00
CHCI cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -39000.00
CHCI balance_sheet (annual, 2025-12-31) — Net PPE: 5706000.00
CHCI balance_sheet (quarterly, 2025-12-31) — Net PPE: 5706000.00
CHCI cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -380000.00
CHCI cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -156000.00
CHCI balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 69822000.00
CHCI balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 69822000.00
CHCI balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 19791000.00
CHCI balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 19791000.00
CHCI balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 960000.00
CHCI balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 960000.00
CHCI balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 18894000.00
CHCI balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 18894000.00
CHCI income_statement (annual, 2025-12-31) — Normalized EBITDA: 12237000.00
CHCI income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 7878000.00
CHCI income_statement (annual, 2025-12-31) — Normalized Income: 17051790.00
CHCI income_statement (quarterly, 2025-12-31) — Normalized Income: 13517660.00
CHCI cash_flow (annual, 2025-12-31) — Operating Cash Flow: 4797000.00
CHCI cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 5257000.00
CHCI cash_flow (annual, 2025-12-31) — Operating Gains Losses: 25000.00
CHCI cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 61000.00
CHCI income_statement (annual, 2025-12-31) — Operating Income: 11930000.00
CHCI income_statement (quarterly, 2025-12-31) — Operating Income: 7749000.00
CHCI income_statement (annual, 2025-12-31) — Operating Revenue: 62861000.00
CHCI income_statement (quarterly, 2025-12-31) — Operating Revenue: 23933000.00
CHCI balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 10092250.00
CHCI balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 10092250.00
CHCI balance_sheet (annual, 2025-12-31) — Other Current Assets: 2018000.00
CHCI balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 2018000.00
CHCI income_statement (annual, 2025-12-31) — Other Income Expense: 140000.00
CHCI income_statement (quarterly, 2025-12-31) — Other Income Expense: -45000.00
CHCI cash_flow (annual, 2025-12-31) — Other Non Cash Items: -67000.00
CHCI cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: -2000.00
CHCI balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 102000.00
CHCI balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 102000.00
CHCI income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 141000.00
CHCI income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 9000.00
CHCI balance_sheet (annual, 2025-12-31) — Other Properties: 5002000.00
CHCI balance_sheet (quarterly, 2025-12-31) — Other Properties: 5002000.00
CHCI balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 847000.00
CHCI balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 847000.00
CHCI cash_flow (annual, 2025-12-31) — Pension And Employee Benefit Expense: 20000.00
CHCI cash_flow (quarterly, 2025-12-31) — Pension And Employee Benefit Expense: 7000.00
CHCI balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 7839000.00
CHCI balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 7839000.00
CHCI income_statement (annual, 2025-12-31) — Pretax Income: 12877000.00
CHCI income_statement (quarterly, 2025-12-31) — Pretax Income: 7889000.00
CHCI cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 112000.00
CHCI cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 0.00
CHCI balance_sheet (annual, 2025-12-31) — Properties: 0.00
CHCI balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
CHCI cash_flow (annual, 2025-12-31) — Purchase Of Investment: -477000.00
CHCI cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -34000.00
CHCI cash_flow (annual, 2025-12-31) — Purchase Of Investment Properties: -57000.00
CHCI cash_flow (quarterly, 2025-12-31) — Purchase Of Investment Properties: 974000.00
CHCI cash_flow (annual, 2025-12-31) — Purchase Of PPE: -380000.00
CHCI cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -156000.00
CHCI balance_sheet (annual, 2025-12-31) — Receivables: 19966000.00
CHCI balance_sheet (quarterly, 2025-12-31) — Receivables: 19966000.00
CHCI income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 48080000.00
CHCI income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 15433000.00
CHCI income_statement (annual, 2025-12-31) — Reconciled Depreciation: 306000.00
CHCI income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 75000.00
CHCI balance_sheet (annual, 2025-12-31) — Retained Earnings: -130719000.00
CHCI balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -130719000.00
CHCI cash_flow (annual, 2025-12-31) — Sale Of Investment: 112000.00
CHCI cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 71000.00
CHCI cash_flow (annual, 2025-12-31) — Sale Of Investment Properties: 289000.00
CHCI income_statement (annual, 2025-12-31) — Selling General And Administration: 2545000.00
CHCI income_statement (quarterly, 2025-12-31) — Selling General And Administration: 676000.00
CHCI balance_sheet (annual, 2025-12-31) — Share Issued: 10178250.00
CHCI balance_sheet (quarterly, 2025-12-31) — Share Issued: 10178250.00
CHCI cash_flow (annual, 2025-12-31) — Stock Based Compensation: 1060000.00
CHCI cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 266000.00
CHCI balance_sheet (annual, 2025-12-31) — Stockholders Equity: 69966000.00
CHCI balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 69966000.00
CHCI balance_sheet (annual, 2025-12-31) — Tangible Book Value: 69822000.00
CHCI balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 69822000.00
CHCI income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -210.00
CHCI income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -11340.00
CHCI income_statement (annual, 2025-12-31) — Tax Provision: -4174000.00
CHCI income_statement (quarterly, 2025-12-31) — Tax Provision: -5586000.00
CHCI income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.21
CHCI income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.21
CHCI balance_sheet (annual, 2025-12-31) — Total Assets: 84962000.00
CHCI balance_sheet (quarterly, 2025-12-31) — Total Assets: 84962000.00
CHCI balance_sheet (annual, 2025-12-31) — Total Capitalization: 69966000.00
CHCI balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 69966000.00
CHCI balance_sheet (annual, 2025-12-31) — Total Debt: 5350000.00
CHCI balance_sheet (quarterly, 2025-12-31) — Total Debt: 5350000.00
CHCI balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 69966000.00
CHCI balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 69966000.00
CHCI income_statement (annual, 2025-12-31) — Total Expenses: 50931000.00
CHCI income_statement (quarterly, 2025-12-31) — Total Expenses: 16184000.00
CHCI balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 14996000.00
CHCI balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 14996000.00
CHCI balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 31696000.00
CHCI balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 31696000.00
CHCI balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 5316000.00
CHCI balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 5316000.00
CHCI income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 11930000.00
CHCI income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 7749000.00
CHCI income_statement (annual, 2025-12-31) — Total Unusual Items: -1000.00
CHCI income_statement (quarterly, 2025-12-31) — Total Unusual Items: -54000.00
CHCI income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -1000.00
CHCI income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -54000.00
CHCI balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 86000.00
CHCI balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 86000.00
CHCI balance_sheet (annual, 2025-12-31) — Treasury Stock: 2662000.00
CHCI balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 2662000.00
CHCI balance_sheet (annual, 2025-12-31) — Working Capital: 43586000.00
CHCI balance_sheet (quarterly, 2025-12-31) — Working Capital: 43586000.00
CHCI income_statement (quarterly, 2026-03-31) — +Operating Expense: 1235000.00
CHCI income_statement (quarterly, 2026-03-31) — +Total Revenue: 17446000.00
CHCI balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 22951000.00
CHCI balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 203100000.00
CHCI income_statement (quarterly, 2026-03-31) — Basic Average Shares: 10204000.00
CHCI income_statement (quarterly, 2026-03-31) — Basic EPS: 0.19
CHCI cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 31282000.00
CHCI cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -1000.00
CHCI balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 5103000.00
CHCI balance_sheet (quarterly, 2026-03-31) — Capital Stock: 102000.00
CHCI balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 19631000.00
CHCI balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 19631000.00
CHCI cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -691000.00
CHCI cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -5183000.00
CHCI cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -5777000.00
CHCI cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 264000.00
CHCI cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: -5373000.00
CHCI cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: 259000.00
CHCI cash_flow (quarterly, 2026-03-31) — Change In Payable: 264000.00
CHCI cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -5109000.00
CHCI cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -193000.00
CHCI cash_flow (quarterly, 2026-03-31) — Change In Receivables: -2985000.00
CHCI cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -8028000.00
CHCI cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -2985000.00
CHCI cash_flow (quarterly, 2026-03-31) — Changes In Cash: -11651000.00
CHCI balance_sheet (quarterly, 2026-03-31) — Common Stock: 102000.00
CHCI balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 71810000.00
CHCI cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 99000.00
CHCI income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 14671000.00
CHCI balance_sheet (quarterly, 2026-03-31) — Current Assets: 43586000.00
CHCI balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 1000000.00
CHCI balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 1000000.00
CHCI balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 4570000.00
CHCI cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: 199000.00
CHCI cash_flow (quarterly, 2026-03-31) — Deferred Tax: 199000.00
CHCI cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 72000.00
CHCI income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 72000.00
CHCI cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 72000.00
CHCI income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 72000.00
CHCI income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 10493000.00
CHCI income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.19
CHCI income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 1989000.00
CHCI cash_flow (quarterly, 2026-03-31) — Dividends Received Cfi: 0.00
CHCI income_statement (quarterly, 2026-03-31) — EBIT: 1540000.00
CHCI income_statement (quarterly, 2026-03-31) — EBITDA: 1612000.00
CHCI cash_flow (quarterly, 2026-03-31) — End Cash Position: 19631000.00
CHCI cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -691000.00
CHCI cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -5778000.00
CHCI cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: -507000.00
CHCI income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: 507000.00
CHCI balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 144000.00
CHCI balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 22951000.00
CHCI balance_sheet (quarterly, 2026-03-31) — Gross PPE: 5400000.00
CHCI income_statement (quarterly, 2026-03-31) — Gross Profit: 2775000.00
CHCI cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: 0.00
CHCI income_statement (quarterly, 2026-03-31) — Interest Income: 129000.00
CHCI income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 129000.00
CHCI cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 156000.00
CHCI balance_sheet (quarterly, 2026-03-31) — Invested Capital: 71810000.00
CHCI cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -5183000.00
CHCI balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 12495000.00
CHCI balance_sheet (quarterly, 2026-03-31) — Investments In Other Ventures Under Equity Method: 12495000.00
CHCI cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 99000.00
CHCI balance_sheet (quarterly, 2026-03-31) — Leases: 22000.00
CHCI balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 4103000.00
CHCI balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 4103000.00
CHCI balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 12495000.00
CHCI cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 99000.00
CHCI income_statement (quarterly, 2026-03-31) — Net Income: 1989000.00
CHCI income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 1989000.00
CHCI income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 1989000.00
CHCI income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 1989000.00
CHCI income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 1989000.00
CHCI cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 1989000.00
CHCI income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 1989000.00
CHCI income_statement (quarterly, 2026-03-31) — Net Interest Income: 129000.00
CHCI cash_flow (quarterly, 2026-03-31) — Net Investment Properties Purchase And Sale: -3374000.00
CHCI cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -1808000.00
CHCI income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 129000.00
CHCI cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -790000.00
CHCI balance_sheet (quarterly, 2026-03-31) — Net PPE: 5400000.00
CHCI cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -1000.00
CHCI balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 71666000.00
CHCI balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 19874000.00
CHCI balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 1203000.00
CHCI balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 18695000.00
CHCI income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 1105000.00
CHCI income_statement (quarterly, 2026-03-31) — Normalized Income: 1528111.97
CHCI cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -5777000.00
CHCI cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -515000.00
CHCI income_statement (quarterly, 2026-03-31) — Operating Income: 1540000.00
CHCI income_statement (quarterly, 2026-03-31) — Operating Revenue: 17446000.00
CHCI balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 10259250.00
CHCI balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 1004000.00
CHCI income_statement (quarterly, 2026-03-31) — Other Income Expense: 519000.00
CHCI cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: -40000.00
CHCI balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 187000.00
CHCI income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 12000.00
CHCI balance_sheet (quarterly, 2026-03-31) — Other Properties: 5378000.00
CHCI balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 1111000.00
CHCI cash_flow (quarterly, 2026-03-31) — Pension And Employee Benefit Expense: -8000.00
CHCI balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 2459000.00
CHCI income_statement (quarterly, 2026-03-31) — Pretax Income: 2188000.00
CHCI balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
CHCI cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -1865000.00
CHCI cash_flow (quarterly, 2026-03-31) — Purchase Of Investment Properties: -3374000.00
CHCI cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -1000.00
CHCI balance_sheet (quarterly, 2026-03-31) — Receivables: 22951000.00
CHCI income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 14671000.00
CHCI income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 72000.00
CHCI balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -128730000.00
CHCI cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 57000.00
CHCI income_statement (quarterly, 2026-03-31) — Selling General And Administration: 1163000.00
CHCI balance_sheet (quarterly, 2026-03-31) — Share Issued: 10345250.00
CHCI cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 546000.00
CHCI balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 71810000.00
CHCI balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 71666000.00
CHCI income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 46111.97
CHCI income_statement (quarterly, 2026-03-31) — Tax Provision: 199000.00
CHCI income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.09
CHCI balance_sheet (quarterly, 2026-03-31) — Total Assets: 81686000.00
CHCI balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 71810000.00
CHCI balance_sheet (quarterly, 2026-03-31) — Total Debt: 5103000.00
CHCI balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 71810000.00
CHCI income_statement (quarterly, 2026-03-31) — Total Expenses: 15906000.00
CHCI balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 9876000.00
CHCI balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 38100000.00
CHCI balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 5306000.00
CHCI income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 1540000.00
CHCI income_statement (quarterly, 2026-03-31) — Total Unusual Items: 507000.00
CHCI income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 507000.00
CHCI balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 86000.00
CHCI balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 2662000.00
CHCI balance_sheet (quarterly, 2026-03-31) — Working Capital: 39016000.00
CHCO cash_flow (annual, 2021-12-31) — Asset Impairment Charge: 0.00
CHCO cash_flow (annual, 2021-12-31) — Gain Loss On Investment Securities: 0.00
CHCO cash_flow (annual, 2021-12-31) — Long Term Debt Payments: 0.00
CHCO income_statement (annual, 2021-12-31) — Other Gand A: 6728000.00
CHCO cash_flow (annual, 2021-12-31) — Purchase Of Business: 0.00
CHCO cash_flow (annual, 2021-12-31) — Repayment Of Debt: 0.00
CHCO income_statement (annual, 2022-12-31) — +Total Revenue: 246078000.00
CHCO balance_sheet (annual, 2022-12-31) — Accounts Receivable: 18287000.00
CHCO balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -106105000.00
CHCO balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 170980000.00
CHCO cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 10451000.00
CHCO cash_flow (annual, 2022-12-31) — Amortization Of Intangibles: 10451000.00
CHCO balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 23807000.00
CHCO income_statement (annual, 2022-12-31) — Basic Average Shares: 14847000.00
CHCO income_statement (annual, 2022-12-31) — Basic EPS: 6.81
CHCO cash_flow (annual, 2022-12-31) — Beginning Cash Position: 634631000.00
CHCO balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 98275000.00
CHCO cash_flow (annual, 2022-12-31) — Capital Expenditure: -2141000.00
CHCO balance_sheet (annual, 2022-12-31) — Capital Stock: 47619000.00
CHCO balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 200000000.00
CHCO balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Federal Funds Sold: 200000000.00
CHCO cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -36702000.00
CHCO balance_sheet (annual, 2022-12-31) — Cash Financial: 70257000.00
CHCO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -139996000.00
CHCO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -410452000.00
CHCO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 115817000.00
CHCO cash_flow (annual, 2022-12-31) — Change In Other Current Assets: -20643000.00
CHCO cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: 20068000.00
CHCO cash_flow (annual, 2022-12-31) — Change In Receivables: -2660000.00
CHCO cash_flow (annual, 2022-12-31) — Change In Working Capital: -3235000.00
CHCO cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -2660000.00
CHCO cash_flow (annual, 2022-12-31) — Changes In Cash: -434631000.00
CHCO balance_sheet (annual, 2022-12-31) — Common Stock: 47619000.00
CHCO cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -36702000.00
CHCO balance_sheet (annual, 2022-12-31) — Common Stock Equity: 577852000.00
CHCO cash_flow (annual, 2022-12-31) — Common Stock Payments: -26449000.00
CHCO balance_sheet (annual, 2022-12-31) — Current Debt: 0.00
CHCO balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 0.00
CHCO cash_flow (annual, 2022-12-31) — Deferred Income Tax: 1469000.00
CHCO cash_flow (annual, 2022-12-31) — Deferred Tax: 1469000.00
CHCO cash_flow (annual, 2022-12-31) — Depreciation: 5325000.00
CHCO cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 15776000.00
CHCO cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 15776000.00
CHCO income_statement (annual, 2022-12-31) — Diluted Average Shares: 14873000.00
CHCO income_statement (annual, 2022-12-31) — Diluted EPS: 6.80
CHCO income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 101113000.00
CHCO cash_flow (annual, 2022-12-31) — End Cash Position: 200000000.00
CHCO cash_flow (annual, 2022-12-31) — Excess Tax Benefit From Stock Based Compensation: -292000.00
CHCO cash_flow (annual, 2022-12-31) — Financing Cash Flow: -139996000.00
CHCO cash_flow (annual, 2022-12-31) — Free Cash Flow: 113676000.00
CHCO cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: 0.00
CHCO income_statement (annual, 2022-12-31) — Gain On Sale Of Security: -1581000.00
CHCO balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -131488000.00
CHCO income_statement (annual, 2022-12-31) — General And Administrative Expense: 68209000.00
CHCO balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 115735000.00
CHCO balance_sheet (annual, 2022-12-31) — Gross PPE: 176891000.00
CHCO cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 22434000.00
CHCO income_statement (annual, 2022-12-31) — Insurance And Claims: 1673000.00
CHCO income_statement (annual, 2022-12-31) — Interest Expense: 9655000.00
CHCO income_statement (annual, 2022-12-31) — Interest Income: 189688000.00
CHCO cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 9467000.00
CHCO cash_flow (annual, 2022-12-31) — Investing Cash Flow: -410452000.00
CHCO balance_sheet (annual, 2022-12-31) — Investments And Advances: 1529327000.00
CHCO cash_flow (annual, 2022-12-31) — Issuance Of Debt: 0.00
CHCO balance_sheet (annual, 2022-12-31) — Land And Improvements: 34325000.00
CHCO cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 0.00
CHCO cash_flow (annual, 2022-12-31) — Long Term Debt Payments: 0.00
CHCO balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 44291000.00
CHCO balance_sheet (annual, 2022-12-31) — Minimum Pension Liabilities: -3422000.00
CHCO cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: 0.00
CHCO cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -26449000.00
CHCO income_statement (annual, 2022-12-31) — Net Income: 102071000.00
CHCO income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 101113000.00
CHCO income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 102071000.00
CHCO income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 102071000.00
CHCO income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 102071000.00
CHCO cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 102071000.00
CHCO income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 102071000.00
CHCO income_statement (annual, 2022-12-31) — Net Interest Income: 180033000.00
CHCO cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -308203000.00
CHCO cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -21494000.00
CHCO cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 0.00
CHCO cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -762000.00
CHCO cash_flow (annual, 2022-12-31) — Net Other Investing Changes: 2693000.00
CHCO balance_sheet (annual, 2022-12-31) — Net PPE: 70786000.00
CHCO cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -1951000.00
CHCO cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: -21494000.00
CHCO balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 462117000.00
CHCO income_statement (annual, 2022-12-31) — Normalized Income: 102285936.00
CHCO income_statement (annual, 2022-12-31) — Occupancy And Equipment: 21037000.00
CHCO cash_flow (annual, 2022-12-31) — Operating Cash Flow: 115817000.00
CHCO cash_flow (annual, 2022-12-31) — Operating Gains Losses: -69000.00
CHCO income_statement (annual, 2022-12-31) — Operating Revenue: 246078000.00
CHCO balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 14788149.00
CHCO balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 0.00
CHCO cash_flow (annual, 2022-12-31) — Other Non Cash Items: -5234000.00
CHCO income_statement (annual, 2022-12-31) — Other Non Interest Expense: 23157000.00
CHCO balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 1505520000.00
CHCO income_statement (annual, 2022-12-31) — Otherunder Preferred Stock Dividend: 958000.00
CHCO cash_flow (annual, 2022-12-31) — Pension And Employee Benefit Expense: 256000.00
CHCO balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
CHCO income_statement (annual, 2022-12-31) — Pretax Income: 127334000.00
CHCO cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 798000.00
CHCO income_statement (annual, 2022-12-31) — Professional Expense And Contract Services Expense: 2194000.00
CHCO cash_flow (annual, 2022-12-31) — Purchase Of Investment: -519564000.00
CHCO cash_flow (annual, 2022-12-31) — Purchase Of PPE: -2141000.00
CHCO balance_sheet (annual, 2022-12-31) — Receivables: 18287000.00
CHCO income_statement (annual, 2022-12-31) — Reconciled Depreciation: 15776000.00
CHCO cash_flow (annual, 2022-12-31) — Repayment Of Debt: 0.00
CHCO cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -26449000.00
CHCO income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: 268000.00
CHCO balance_sheet (annual, 2022-12-31) — Retained Earnings: 706696000.00
CHCO income_statement (annual, 2022-12-31) — Salaries And Wages: 66536000.00
CHCO cash_flow (annual, 2022-12-31) — Sale Of Business: 0.00
CHCO cash_flow (annual, 2022-12-31) — Sale Of Investment: 211361000.00
CHCO cash_flow (annual, 2022-12-31) — Sale Of PPE: 190000.00
CHCO income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 3405000.00
CHCO income_statement (annual, 2022-12-31) — Selling General And Administration: 71614000.00
CHCO balance_sheet (annual, 2022-12-31) — Share Issued: 19047548.00
CHCO income_statement (annual, 2022-12-31) — Special Income Charges: -268000.00
CHCO cash_flow (annual, 2022-12-31) — Stock Based Compensation: 3276000.00
CHCO balance_sheet (annual, 2022-12-31) — Stockholders Equity: 577852000.00
CHCO balance_sheet (annual, 2022-12-31) — Tangible Book Value: 462117000.00
CHCO income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -53064.00
CHCO income_statement (annual, 2022-12-31) — Tax Provision: 25263000.00
CHCO income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.20
CHCO balance_sheet (annual, 2022-12-31) — Total Assets: 5878106000.00
CHCO balance_sheet (annual, 2022-12-31) — Total Debt: 0.00
CHCO balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 577852000.00
CHCO balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 5300254000.00
CHCO income_statement (annual, 2022-12-31) — Total Unusual Items: -268000.00
CHCO income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -268000.00
CHCO balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 4259399.00
CHCO balance_sheet (annual, 2022-12-31) — Treasury Stock: 215955000.00
CHCO balance_sheet (annual, 2022-12-31) — Unrealized Gain Loss: -128066000.00
CHCO cash_flow (annual, 2022-12-31) — Unrealized Gain Loss On Investment Securities: 1581000.00
CHCO income_statement (annual, 2023-12-31) — +Total Revenue: 282423000.00
CHCO balance_sheet (annual, 2023-12-31) — Accounts Receivable: 20290000.00
CHCO balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -110041000.00
CHCO balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 177424000.00
CHCO cash_flow (annual, 2023-12-31) — Amortization Cash Flow: 6165000.00
CHCO cash_flow (annual, 2023-12-31) — Amortization Of Intangibles: 6165000.00
CHCO balance_sheet (annual, 2023-12-31) — Available For Sale Securities: 30966000.00
CHCO income_statement (annual, 2023-12-31) — Basic Average Shares: 14868000.00
CHCO income_statement (annual, 2023-12-31) — Basic EPS: 7.62
CHCO cash_flow (annual, 2023-12-31) — Beginning Cash Position: 200000000.00
CHCO balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 101279000.00
CHCO cash_flow (annual, 2023-12-31) — Capital Expenditure: -2962000.00
CHCO balance_sheet (annual, 2023-12-31) — Capital Stock: 47619000.00
CHCO balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 156276000.00
CHCO balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Federal Funds Sold: 156276000.00
CHCO cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -39993000.00
CHCO balance_sheet (annual, 2023-12-31) — Cash Financial: 123033000.00
CHCO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -195984000.00
CHCO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: 14680000.00
CHCO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 137580000.00
CHCO cash_flow (annual, 2023-12-31) — Change In Other Current Assets: 14422000.00
CHCO cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -3203000.00
CHCO cash_flow (annual, 2023-12-31) — Change In Receivables: -1136000.00
CHCO cash_flow (annual, 2023-12-31) — Change In Working Capital: 10083000.00
CHCO cash_flow (annual, 2023-12-31) — Changes In Account Receivables: -1136000.00
CHCO cash_flow (annual, 2023-12-31) — Changes In Cash: -43724000.00
CHCO balance_sheet (annual, 2023-12-31) — Common Stock: 47619000.00
CHCO cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -39993000.00
CHCO balance_sheet (annual, 2023-12-31) — Common Stock Equity: 677066000.00
CHCO cash_flow (annual, 2023-12-31) — Common Stock Payments: -60134000.00
CHCO balance_sheet (annual, 2023-12-31) — Current Debt: 25000000.00
CHCO balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 25000000.00
CHCO cash_flow (annual, 2023-12-31) — Deferred Income Tax: -2764000.00
CHCO cash_flow (annual, 2023-12-31) — Deferred Tax: -2764000.00
CHCO cash_flow (annual, 2023-12-31) — Depreciation: 4556000.00
CHCO cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 10721000.00
CHCO cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 10721000.00
CHCO income_statement (annual, 2023-12-31) — Diluted Average Shares: 14891000.00
CHCO income_statement (annual, 2023-12-31) — Diluted EPS: 7.61
CHCO income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 113329000.00
CHCO cash_flow (annual, 2023-12-31) — End Cash Position: 156276000.00
CHCO cash_flow (annual, 2023-12-31) — Excess Tax Benefit From Stock Based Compensation: 228000.00
CHCO cash_flow (annual, 2023-12-31) — Financing Cash Flow: -195984000.00
CHCO cash_flow (annual, 2023-12-31) — Free Cash Flow: 134618000.00
CHCO income_statement (annual, 2023-12-31) — Gain On Sale Of Security: -4476000.00
CHCO balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -110539000.00
CHCO income_statement (annual, 2023-12-31) — General And Administrative Expense: 76085000.00
CHCO balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 162568000.00
CHCO balance_sheet (annual, 2023-12-31) — Gross PPE: 182187000.00
CHCO cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 32813000.00
CHCO income_statement (annual, 2023-12-31) — Insurance And Claims: 2922000.00
CHCO income_statement (annual, 2023-12-31) — Interest Expense: 52023000.00
CHCO income_statement (annual, 2023-12-31) — Interest Income: 271264000.00
CHCO cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 49134000.00
CHCO balance_sheet (annual, 2023-12-31) — Invested Capital: 802066000.00
CHCO cash_flow (annual, 2023-12-31) — Investing Cash Flow: 14680000.00
CHCO balance_sheet (annual, 2023-12-31) — Investments And Advances: 1369103000.00
CHCO cash_flow (annual, 2023-12-31) — Issuance Of Debt: 100000000.00
CHCO balance_sheet (annual, 2023-12-31) — Land And Improvements: 35135000.00
CHCO balance_sheet (annual, 2023-12-31) — Long Term Debt: 100000000.00
CHCO balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 100000000.00
CHCO cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 100000000.00
CHCO balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 45773000.00
CHCO balance_sheet (annual, 2023-12-31) — Minimum Pension Liabilities: -2581000.00
CHCO cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: 14016000.00
CHCO cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -60134000.00
CHCO income_statement (annual, 2023-12-31) — Net Income: 114365000.00
CHCO income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 113329000.00
CHCO income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 114365000.00
CHCO income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 114365000.00
CHCO income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 114365000.00
CHCO cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 114365000.00
CHCO income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 114365000.00
CHCO income_statement (annual, 2023-12-31) — Net Interest Income: 219241000.00
CHCO cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 224323000.00
CHCO cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 137392000.00
CHCO cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 100000000.00
CHCO cash_flow (annual, 2023-12-31) — Net Other Financing Charges: 1071000.00
CHCO cash_flow (annual, 2023-12-31) — Net Other Investing Changes: 2805000.00
CHCO balance_sheet (annual, 2023-12-31) — Net PPE: 72146000.00
CHCO cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -2679000.00
CHCO cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: 37392000.00
CHCO balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 514498000.00
CHCO income_statement (annual, 2023-12-31) — Normalized Income: 118479850.00
CHCO income_statement (annual, 2023-12-31) — Occupancy And Equipment: 21076000.00
CHCO cash_flow (annual, 2023-12-31) — Operating Cash Flow: 137580000.00
CHCO cash_flow (annual, 2023-12-31) — Operating Gains Losses: -95000.00
CHCO income_statement (annual, 2023-12-31) — Operating Revenue: 282423000.00
CHCO balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 14831817.00
CHCO balance_sheet (annual, 2023-12-31) — Other Current Borrowings: 25000000.00
CHCO cash_flow (annual, 2023-12-31) — Other Non Cash Items: -5890000.00
CHCO income_statement (annual, 2023-12-31) — Other Non Interest Expense: 28616000.00
CHCO balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 1338137000.00
CHCO income_statement (annual, 2023-12-31) — Otherunder Preferred Stock Dividend: 1036000.00
CHCO cash_flow (annual, 2023-12-31) — Pension And Employee Benefit Expense: 52000.00
CHCO balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
CHCO income_statement (annual, 2023-12-31) — Pretax Income: 143106000.00
CHCO cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 0.00
CHCO income_statement (annual, 2023-12-31) — Professional Expense And Contract Services Expense: 2035000.00
CHCO cash_flow (annual, 2023-12-31) — Purchase Of Investment: -101710000.00
CHCO cash_flow (annual, 2023-12-31) — Purchase Of PPE: -2962000.00
CHCO balance_sheet (annual, 2023-12-31) — Receivables: 20290000.00
CHCO income_statement (annual, 2023-12-31) — Reconciled Depreciation: 10721000.00
CHCO cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -60134000.00
CHCO income_statement (annual, 2023-12-31) — Restructuring And Mergern Acquisition: 5150000.00
CHCO balance_sheet (annual, 2023-12-31) — Retained Earnings: 780299000.00
CHCO income_statement (annual, 2023-12-31) — Salaries And Wages: 73163000.00
CHCO cash_flow (annual, 2023-12-31) — Sale Of Business: 14016000.00
CHCO cash_flow (annual, 2023-12-31) — Sale Of Investment: 326033000.00
CHCO cash_flow (annual, 2023-12-31) — Sale Of PPE: 283000.00
CHCO income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 3112000.00
CHCO income_statement (annual, 2023-12-31) — Selling General And Administration: 79197000.00
CHCO balance_sheet (annual, 2023-12-31) — Share Issued: 19047548.00
CHCO income_statement (annual, 2023-12-31) — Special Income Charges: -5150000.00
CHCO cash_flow (annual, 2023-12-31) — Stock Based Compensation: 3213000.00
CHCO balance_sheet (annual, 2023-12-31) — Stockholders Equity: 677066000.00
CHCO balance_sheet (annual, 2023-12-31) — Tangible Book Value: 514498000.00
CHCO income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -1035150.00
CHCO income_statement (annual, 2023-12-31) — Tax Provision: 28741000.00
CHCO income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.20
CHCO balance_sheet (annual, 2023-12-31) — Total Assets: 6168052000.00
CHCO balance_sheet (annual, 2023-12-31) — Total Capitalization: 777066000.00
CHCO balance_sheet (annual, 2023-12-31) — Total Debt: 125000000.00
CHCO balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 677066000.00
CHCO balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 5490986000.00
CHCO income_statement (annual, 2023-12-31) — Total Unusual Items: -5150000.00
CHCO income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -5150000.00
CHCO balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 4215731.00
CHCO balance_sheet (annual, 2023-12-31) — Treasury Stock: 217737000.00
CHCO balance_sheet (annual, 2023-12-31) — Unrealized Gain Loss: -107958000.00
CHCO cash_flow (annual, 2023-12-31) — Unrealized Gain Loss On Investment Securities: 4476000.00
CHCO balance_sheet (quarterly, 2024-09-30) — Current Debt: 0.00
CHCO balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 0.00
CHCO cash_flow (quarterly, 2024-09-30) — Long Term Debt Payments: -220000.00
CHCO cash_flow (quarterly, 2024-09-30) — Net Business Purchase And Sale: 0.00
CHCO balance_sheet (quarterly, 2024-09-30) — Other Current Borrowings: 0.00
CHCO cash_flow (quarterly, 2024-09-30) — Repayment Of Debt: -220000.00
CHCO income_statement (quarterly, 2024-09-30) — Restructuring And Mergern Acquisition: 0.00
CHCO cash_flow (quarterly, 2024-09-30) — Sale Of Business: 0.00
CHCO income_statement (quarterly, 2024-09-30) — Special Income Charges: 0.00
CHCO income_statement (annual, 2024-12-31) — +Total Revenue: 285062000.00
CHCO balance_sheet (annual, 2024-12-31) — Accounts Receivable: 20650000.00
CHCO balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -106776000.00
CHCO balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -106776000.00
CHCO balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 176506000.00
CHCO cash_flow (annual, 2024-12-31) — Amortization Cash Flow: 8984000.00
CHCO cash_flow (annual, 2024-12-31) — Amortization Of Intangibles: 8984000.00
CHCO balance_sheet (annual, 2024-12-31) — Available For Sale Securities: 29803000.00
CHCO income_statement (annual, 2024-12-31) — Basic Average Shares: 14676000.00
CHCO income_statement (annual, 2024-12-31) — Basic EPS: 7.89
CHCO cash_flow (annual, 2024-12-31) — Beginning Cash Position: 156276000.00
CHCO balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 102342000.00
CHCO balance_sheet (quarterly, 2024-12-31) — Buildings And Improvements: 102342000.00
CHCO cash_flow (annual, 2024-12-31) — Capital Expenditure: -2706000.00
CHCO balance_sheet (annual, 2024-12-31) — Capital Stock: 47619000.00
CHCO balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 225389000.00
CHCO balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Federal Funds Sold: 225389000.00
CHCO cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -43482000.00
CHCO balance_sheet (annual, 2024-12-31) — Cash Financial: 117580000.00
CHCO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 189477000.00
CHCO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -252260000.00
CHCO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 131896000.00
CHCO cash_flow (annual, 2024-12-31) — Change In Other Current Assets: 5036000.00
CHCO cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -7910000.00
CHCO cash_flow (annual, 2024-12-31) — Change In Receivables: -360000.00
CHCO cash_flow (annual, 2024-12-31) — Change In Working Capital: -3234000.00
CHCO cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -360000.00
CHCO cash_flow (annual, 2024-12-31) — Changes In Cash: 69113000.00
CHCO balance_sheet (annual, 2024-12-31) — Common Stock: 47619000.00
CHCO cash_flow (annual, 2024-12-31) — Common Stock Dividend Paid: -43482000.00
CHCO balance_sheet (annual, 2024-12-31) — Common Stock Equity: 730664000.00
CHCO cash_flow (annual, 2024-12-31) — Common Stock Payments: -17896000.00
CHCO balance_sheet (annual, 2024-12-31) — Current Debt: 0.00
CHCO balance_sheet (quarterly, 2024-12-31) — Current Debt: 0.00
CHCO balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 0.00
CHCO balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 0.00
CHCO cash_flow (annual, 2024-12-31) — Deferred Income Tax: 381000.00
CHCO cash_flow (annual, 2024-12-31) — Deferred Tax: 381000.00
CHCO cash_flow (annual, 2024-12-31) — Depreciation: 4215000.00
CHCO cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 13199000.00
CHCO cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 13199000.00
CHCO income_statement (annual, 2024-12-31) — Diluted Average Shares: 14697000.00
CHCO income_statement (annual, 2024-12-31) — Diluted EPS: 7.89
CHCO income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 116032000.00
CHCO cash_flow (annual, 2024-12-31) — End Cash Position: 225389000.00
CHCO cash_flow (annual, 2024-12-31) — Excess Tax Benefit From Stock Based Compensation: 387000.00
CHCO cash_flow (annual, 2024-12-31) — Financing Cash Flow: 189477000.00
CHCO cash_flow (annual, 2024-12-31) — Free Cash Flow: 129190000.00
CHCO income_statement (annual, 2024-12-31) — Gain On Sale Of Security: -2650000.00
CHCO balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -115719000.00
CHCO income_statement (annual, 2024-12-31) — General And Administrative Expense: 79255000.00
CHCO balance_sheet (annual, 2024-12-31) — Goodwill: 149762000.00
CHCO balance_sheet (quarterly, 2024-12-31) — Goodwill: 149762000.00
CHCO balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 160044000.00
CHCO balance_sheet (annual, 2024-12-31) — Gross PPE: 177315000.00
CHCO balance_sheet (quarterly, 2024-12-31) — Gross PPE: 177315000.00
CHCO cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 28040000.00
CHCO income_statement (annual, 2024-12-31) — Insurance And Claims: 2892000.00
CHCO income_statement (annual, 2024-12-31) — Interest Expense: 86192000.00
CHCO income_statement (annual, 2024-12-31) — Interest Income: 306429000.00
CHCO cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 83804000.00
CHCO balance_sheet (annual, 2024-12-31) — Invested Capital: 880664000.00
CHCO cash_flow (annual, 2024-12-31) — Investing Cash Flow: -252260000.00
CHCO balance_sheet (annual, 2024-12-31) — Investments And Advances: 757109000.00
CHCO cash_flow (annual, 2024-12-31) — Issuance Of Debt: 50000000.00
CHCO cash_flow (quarterly, 2024-12-31) — Issuance Of Debt: 0.00
CHCO balance_sheet (annual, 2024-12-31) — Land And Improvements: 35163000.00
CHCO balance_sheet (quarterly, 2024-12-31) — Land And Improvements: 35163000.00
CHCO balance_sheet (annual, 2024-12-31) — Long Term Debt: 150000000.00
CHCO balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 150000000.00
CHCO cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 50000000.00